New hope for pain sufferers

PIC: Bigstock

Research shows a staggering number of us are using codeine to battle pain, but with it becoming prescription only this week, a new test can determine a suitable solution to manage pain.

As codeine is taken off the shelves for over-the-counter purchase this week new research has revealed one in three Australians have used the painkiller in the last year.

Research conducted by genetic interpretation company myDNA found of the 35% of Aussies who chow down on the meds two thirds said they purchased them over the counter, while one in four of us admit our pain still isn't under control after we've taken codeine. 

As codeine availability changes this Thursday, February 1, a new mouth swab test will help give people with pain new hope in managing it.

The swab works by analysing an individual’s genetic code and determines how our body responds to different pain relief medication and determines the most suitable solutions for pain management.

The effect of codeine is largely determined by the genes we inherit from our parents.

Experts say our genetic makeup can play a significant role in codeine being rendered ineffective or in some cases, being metabolised too quickly, which increases the risk of a morphine overdose. 

Meanwhile, one in five people who use codeine are currently stockpiling supplies.

The study found pain sufferers are concerned about pain management with doctors reluctant to prescribe codeine and after their codeine stocks deplete.  

Mouth swabs are available to anyone, provided by a health care professional. 

 

More from Local News

Fuel Watch
  • 179.9: EG Ampol Falcon
  • 179.9: Ampol Foodary Falcon (Miami Beach)
  • 183.9: Ampol Foodary North Yunderup
  • 184.9: Ampol Foodary Lakelands
  • 185.9: 7-Eleven Greenfields